Competitive intelligence. Solved.

Pharma data for competitive landscapes, due diligence, and AI-powered research.

What pharma data or intelligence do you need?

Trusted by teams in life science investing, biotech and pharma

Today's approach can't answer your billion-dollar questions.

Which drug candidates outperform the standard of care?: It takes a month to gather the safety and efficacy data. Ten drugs from China are missing. Results weren't found for 50 drugs.
What is the likelihood that this drug gets approved?: Current predictions are based on broad benchmarks that are not applicable to your asset.
How much is this drug worth?: NPV models are predicated on many fragile assumptions that each rely on incomplete data.
Which drug programs should we discontinue and which should we keep?: A drug with a similar mechanism was discontinued for toxicity, but your risk assessment wasn't updated, leading to unnecessary investment.

Your assistant. Gosset’s data.

Keep ChatGPT or Claude.
Add Gosset.

Connect Gosset to the AI you already use. Give it a comprehensive, continuously updated pharma dataset to build on.

ChatGPT / ClaudeWith web search

70%done

AI assistants are good at turning the pages they find into a useful starting point.

Your assistant +

Gosset

99%done

Ground the report in connected pharma data, pulled directly for your question.

70% → 99% illustrates the ambition for completeness.

Connected records reveal the assets, trials and relationships a casual search can miss.

Pull the relevant dataset in one query, saving the search-and-extract loop for questions that need it.

Fewer pages to read and fewer extraction steps can lower the AI cost of gathering evidence.

What you can do with Gosset

Competitive Intelligence·Search & Evaluation·Trial Outcome Forecasting·Asset Due Diligence·Portfolio Optimization

Monitor

Safety, efficacy, trial design, and biomarker data for every trial with disclosed results. Coverage no other platform matches.
Generate comprehensive landscapes for niche and nuanced indications with IP, pricing, and detailed development status.
Efficiently understand each drug's market positioning.
Get up to speed on the standard of care with reports backed by drug labels and current treatment guidelines.

Source

Identify drug candidates that outperform the standard of care.
Generate the short list of legitimate acquisition targets from among hundreds of pipeline assets
Assess target validation, competitive crowding, and market potential.
Get sensitive and specific drug lists from complex, specific queries.

Predict

Validated, calibrated predictions of the probability of technical and regulatory success of clinical trials
Trial completion-date forecasts that land 47 days closer to the true date than sponsors' own predictions
Custom models tuned to your company's historical trials

Validate

Leverages your proprietary data alongside Gosset's knowledge graph
Target validation that draws from data on competing and discontinued drugs
Safety, efficacy, and benchmarking against competitors
Total addressable market calculations informed by comprehensive pricing data and detailed epidemiology
Patent portfolio, composition of matter expiration, regulatory designations, and exclusivity timelines
Detailed, evidence-based risk analysis

Prioritize

Personalized recommendations based on current pipeline, investment resources, and opportunities
Accounts for cumulative time, cost, and likelihood of success in all remaining trials for each asset
Constantly monitors competitor development events and updates risk assessments